Related Experiment Videos

Opsonic activity of myeloma immunoglobulins (MM-Ig)

Insights

Multiple myeloma patients

Area of Science:

  • Immunology
  • Hematology
  • Microbiology

Background:

  • Patients with multiple myeloma (MM) face a heightened risk of severe bacterial infections.
  • These infections are often caused by pathogens requiring opsonization for effective phagocytosis by granulocytes.

Purpose of the Study:

  • To investigate the opsonic activity of immunoglobulin (Ig) from multiple myeloma (MM) patients for zymosan particles.
  • To determine the contribution of Ig to the opsonization process using a neutrophil chemiluminescence (CL) assay.

Main Methods:

  • Utilized a neutrophil chemiluminescence (CL) assay to measure opsonization.
  • Compared opsonic activity in serum lacking Ig to normal serum.
  • Assessed the opsonic capacity of normal IgG, MM-IgG, and MM-IgA in the presence of complement.

Main Results:

  • Serum lacking Ig showed significantly reduced opsonic activity (69% of normal serum).
  • Normal serum concentrations of IgG and IgA from MM patients lacked intrinsic opsonic activity for zymosan.
  • Both MM-IgG and MM-IgA, when combined with complement, restored normal opsonic activity.
  • Increased Ig concentration in MM serum did not inhibit this opsonic function.

Conclusions:

  • Immunoglobulin G (IgG) and Immunoglobulin A (IgA) from multiple myeloma patients can function as effective, non-specific opsonins.
  • These findings suggest a potential mechanism for enhancing immune defense against bacterial infections in MM patients.

Related Concept Videos